Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia

Recruiting Observational Study
Anemia Pregnancy Micronutrients Supplement Health Systems Supply Chain Vulnerabilities Adherence
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
710 (estimated)
Sponsor
University of British Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Malnutrition among pregnant women in low- and middle-income countries (LMICs) can cause micronutrient deficiencies that result in adverse maternal and neonatal health outcomes. The World Health Organization has recently recommended antenatal multiple micronutrient supplementation (MMS) that includes iron and folic acid (IFA) to improve maternal and neonatal health outcomes. MMS likely provides add…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
For the cohort of pregnant individuals consuming MMS: Inclusion Criteria: * Current pregnant * At least 18 years of age * Have attended at least one ANC visit at a health center or hospital in Takeo during the study period * Can provide a functioning phone number for follow-up contact * Willingnes…
Contacts

Meng Sokchea Program Manager, Helen Keller International, MD

+855 023 213 217

MSokchea@hki.org

CONTACT

Vannary Hun, MPH

+855 12 612 912

vhun@hki.org

CONTACT